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Introduction

T

he coronavirus disease 2019 (COVID-19) pandemic
has been cataclysmic, revealing the troubling depth of
health inequities in the United States. Disproportionately
higher rates of COVID-19 infection, hospitalizations, and
deaths among Black Americans were documented in multiple
cities throughout the United States. Upstream causes of these
disparities are related to decades of discriminatory policies
resulting in inequities among housing quality, economic
opportunities, education, criminal justice, and health care.1,2
As a result, Black Americans are more likely to live in impoverished neighborhoods – environments associated with
adverse outcomes related to COVID-19 infection. These
communities were severely disadvantaged by significant
barriers to testing in the early phases of the pandemic, by
employment in sectors that required in-person interaction or
suffered significant layoffs, and by living environments that
were not as amenable to social distancing.3,4 The conditions
in which people live, work, and play – or social determinants
of health (SDOH) – deeply fostered the devastating impact
COVID-19 had on these communities.
The pandemic has led to a new sense of urgency to address
SDOH. Urban academic medical centers provide health services to a significant percentage of patients from impoverished
communities, and therapeutic innovations from pharmaceutical corporations will only have a desired impact if they are
able to be implemented across at-risk populations equitably.
Acknowledging and understanding upstream SDOH is imperative to truly achieving better health outcomes.
From an entrepreneurial perspective, there is emerging interest from digital health companies to develop
technologies that either monitor health, measure health
statistics, or connect vulnerable populations to resources.

Cityblock Health and Unite Us are companies that have
undergone rapid growth aiming to connect vulnerable
populations with services that promote health and ultimately lower high-cost utilization.5,6 Other examples include Google’s Healthcare Natural Language API, which
translates SDOH information into action-based reports
for physicians, and rideshare companies such as Uber and Lyft
that have partnered with health care institutions to overcome transportation barriers for patients, providing free or
reduced cost rides.7
The pandemic led to a rapid acceleration of telehealth that
fueled major mergers, most notably that of Teladoc and Livongo, two of the largest publicly traded virtual care companies.8 This merger created a health technology giant, marking
the beginning of a rapidly expanding future for digital health.
In 2020, more health care companies went public than in the
past 5 years combined.9 Recognizing that aging populations
represent a sizable group that could potentially benefit from
coordination of care, prominent primary care organizations
such as Oak Street Health and Accolade were among those
with high valuations in the initial public offering market,
marking a major shift in the economic valuation of clinical
care provider entities that treat primarily Medicare patients.
These trends indicate the potential for major changes in
health care delivery, as the future largely points to a robust
landscape of digital health technology and a growing understanding of the role of social determinants in determining
health outcomes. As we focus on the profound lack of equity
in health outcomes for racial and ethnic minorities in the
United States today, interventions to address these issues
must also be profound. This is where we predict a new
paradigm – a unique partnership between academic medicine and the pharmaceutical industry to leverage resources
addressing these issues in a timely manner.
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Call to Action

Historically, relationships between pharmaceutical industries and academic medicine have been fraught with
challenges. An example is the inclusion of the Sunshine Act
in the 2010 Affordable Care Act that served as a deterrent to
collaboration given the need to report detailed information
about payments and other ‘‘transfers of value’’ from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals.10 However, recognition of
the toll the pandemic has taken on vulnerable populations
has served as a catalyst for action. It was with this realization that an academic medical center in Philadelphia,
Pennsylvania, Thomas Jefferson University, and pharmaceutical manufacturer, Novartis Pharmaceuticals Corporation (Novartis), came together with a joint mission of
promoting health equity to reduce cardiovascular disease
morbidity and mortality.
Thomas Jefferson University established the Philadelphia
Collaborative for Health Equity (P-CHE) in 2017, a major
vehicle to convene communities with local and regional
stakeholders, prioritize community health needs, and implement strategies to address those needs.11 P-CHE initiatives take a grassroots approach to build trust and
co-develop robust infrastructure designed to enhance the
lives and well-being of those in the community.11 A recent
example is the establishment of the Frazier Family Coalition for Stroke Education and Prevention – an initiative
designed to address the 35-times higher rate of stroke in the
North Philadelphia community. The Coalition will build
community capacity and connect individuals to vital resources, including cardiovascular risk reduction programs
and services.
Likewise, Novartis has supported several population
health programs. For example, the Novartis Foundation, an
independent foundation that aims to promote health and
well-being among underserved populations, has led the
Better Hearts Better Cities initiative. This initiative partnered with government authorities in low- and middleincome countries to address hypertension – the leading risk
factor for cardiovascular disease and a major cause of
death worldwide.12 Using the comprehensive CARDIO
approach described in the Urban Population Health
Toolkit,13 the initiative saw tremendous results, with preliminary findings indicating tripled blood pressure control
in Dakar, Senegal within just 2 years of project implementation.12 Similarly, in Sao Paulo, Brazil, preliminary data showed that blood pressure control tripled after
only 1.5 years of implementation, reaching a better control
rate than in some European countries.12 Novartis aims to
leverage these learnings and best practices to improve
cardiovascular population health in the United States.
In 2020, as a response to worsening health outcomes resulting from the COVID-19 pandemic, the Novartis US
Foundation announced a $25 million commitment to develop partnerships and fund community programs designed
to approach health equity. This commitment posed a novel
question: How can the pharmaceutical industry and academic medicine leverage unique resources to promote health
equity within an urban environment in a way that is inclusive and representative of the communities in which they
seek to serve?
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Born out of a desire to address this question, Jefferson
and Novartis designed Closing the Gap – an initiative to
promote health equity and improve cardiovascular disease
outcomes in target high-risk zip codes across Philadelphia.
Cardiovascular disease remains the leading cause of death
for both men and women in the United States, and Philadelphia is no exception – in 2019, cardiovascular disease accounted for approximately 24% of total deaths
in the city.14 Philadelphia is also the poorest large city
in the United States, with 25% of the population living
at or below the federal poverty level.15 Major risk factors for cardiovascular disease – hypertension, diabetes,
and high cholesterol – are highest among non-Hispanic
Black populations and in areas with the highest rates of
poverty.
Closing the Gap will invest directly in 5 zip codes in the
North and South regions of Philadelphia, expanding and
strengthening existing infrastructure and connecting individuals to the care they need. Initiatives will address health
at the social determinant level, ensuring local participation
by providing operational and financial support to community organizations that already may be providing services to
community members in a setting that is familiar and comfortable. Additionally, a robust screening and community
health worker program will ensure that individuals are assessed for cardiovascular disease risk factors and connected
with programs designed to reduce their risk while also
making certain they receive the resources needed to optimize health – whether that is in the form of a nutrition meal
service, transportation and travel assistance, or connection
to a specialty care provider. Closing the Gap also will aim to
address policy and structural issues and concerns through
community capacity building and advocacy.
Closing the Gap is an example of the type of initiative
that can emerge when partners are focused on addressing
root causes of health disparities. As we begin to move forward in a post-pandemic world, we must not forget the
grounding reality we faced. No single entity is equipped to
tackle the multifaceted issues that drive SDOH, and innovative partnerships similar to the one we have described will
propel us in the right direction.
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